Introduction Human immunodeficiency virus (HIV) infected individuals are at increased risk
of developing active tuberculosis (TB). TB incidence remains higher than in non-HIV …

SETTING: Public human immunodeficiency virus (HIV) clinic and tuberculosis (TB) clinics in
Kampala, Uganda. OBJECTIVE: To examine TB-specific CD4 T-cell single and …

OBJECTIVE: To assess the association of smoking with the interferon-gamma (IFN-γ)
release assay and tuberculin skin test (TST) results in a comparative study on the detection …

Background The risk of tuberculosis (TB) is higher in human immunodeficiency virus (HIV)-
infected patients and intravenous drug users (IDUs). We determined the prevalence and risk …

Background In developing countries, tuberculosis (TB) is a major public health problem and
the leading cause of death among patients with HIV (Human Immunodeficiency Virus). Until …

Background In many settings, the benefits of antiretroviral therapy (ART) are reduced by the
high early incidence of tuberculosis and tuberculosis-associated immune reconstitution …

Background: Tuberculosis (TB) remains a major cause of global morbidity and mortality,
especially in the context of HIV coinfection because immunity is not completely restored …

The tuberculin skin test (TST) is widely used for predicting tuberculosis (TB) in patients with
HIV. However, false-negative results are problematic, especially for immunosuppressed …

OBJECTIVE: To determine the prevalence and predictors of positive interferon-gamma
release assays (IGRAs) and tuberculin skin tests (TSTs) in human immunodeficiency virus …

Background Interferon-gamma release assays (IGRAs) have been used to identify
individuals at risk for developing active tuberculosis (TB). However, data regarding the risk …